Stop Chinese Fentanyl Act of 2025
Current understanding
The Stop Chinese Fentanyl Act of 2025 would expand the Fentanyl Sanctions Act framework by designating certain Chinese entities and senior officials that produce, sell, or abet synthetic opioid trafficking as foreign opioid traffickers subject to mandatory sanctions. It extends the annual foreign opioid trafficker reporting requirement through 2029 and adds a procedural gate requiring Treasury to publish a cost-benefit analysis before issuing IEEPA economic regulations tied to a drug-trafficking national emergency. Status: introduced; practical effect depends on Executive Branch designation practice and OFAC implementation.
Evidence log
- 2024-12-17 — CCP Fentanyl Sanctions Act: cross-connection with ccp-fentanyl-sanctions: Both are introduced House measures targeting PRC-linked fentanyl actors via sanctions authorities. (novelty: 2)
- 2026-02-12 — CBW Fentanyl Act: cross-connection with cbw-fentanyl-act-sanctions: Both target state-linked fentanyl supply chains via sanctions authorities, but the CBW Fentanyl Act uniquely ties fentanyl-related molecule programs to chemical/biological weapons sanctions authorities. (novelty: 3)
- 2025-09-03 — Stop Chinese Fentanyl Act of 2025: cross-connection with transnational-criminal-organizations-national-emergency: Both operate against drug-trafficking organizations under national emergency/IEEPA authorities; the bill adds a cost-benefit analysis prerequisite to IEEPA economic regulations issued under such an emergency. (novelty: 2)